Dr. Shapiro is Chairman of the Department of Oncology at the Johns Hopkins Bayview Medical Center and Medical Director of the Johns Hopkins Program in Geriatric Oncology. He also serves as a faculty member of the Breast Cancer Program for the Johns Hopkins Avon Foundation Breast Center.

He received his undergraduate degree from Michigan State University and his M.D. from George Washington University. He completed his residency in internal medicine and a hematology fellowship at Northwestern University in Chicago. He completed a medical oncology fellowship with B.J. Kennedy at the University of Minnesota.

Dr. Deborah K. Armstrong received a bachelor's degree in bacteriology from the University of California at Berkeley then attended the George Washington University School of Medicine. While at George Washington, she was elected to the Alpha Omega Alpha medical honor society and was awarded the American Medical Women's Association Scholarship Achievement Citation. Dr. Armstrong received her MD degree with distinction then completed training in internal medicine at the University of Pittsburgh and served as Chief Medical Resident. Dr. Armstrong trained in medical oncology as a fellow at the Johns Hopkins Oncology Center. During her oncology training Dr. Armstrong was awarded fellowships from the Susan G. Koman Foundation and the Stetler Research Fund. Since joining the Johns Hopkins faculty, Dr. Armstrong has received a Young Investigator Award from the American Society of Clinical Oncology, a Ladies Home Journal Breakthrough Achievement Award and has twice received the Johns Hopkins University Department of Medicine Osler Housestaff Teaching Award.

Dr. Armstrong works primarily in the area of women's malignancies, with a particular emphasis on breast cancer, ovarian cancer and other gynecologic malignancies, and the genetics of breast and ovarian cancer. Dr. Armstrong's clinical focus is on the development of new therapeutic approaches to the treatment of breast cancer and gynecologic malignancies. Particular areas of interest are intraperitoneal therapy, targeted biologic therapy and immunologic approaches to cancer treatment. Dr. Armstrong also directs the Johns Hopkins Breast and Ovarian Cancer Screening Service, a genetic counseling service that focuses on identifying patients at risk for cancer and examination of new strategies for cancer screening and prevention.

Dr. Armstrong has lectured locally, nationally and internationally. She is active in the Gynecologic Oncology Group, serving on the Medical Oncology, Developmental Therapeutics and Phase I GOG committees and as chair of several clinical trials through this group. Dr. Armstrong serves as a representative of Johns Hopkins to the National Cooperative Cancer Network serving on the ovarian cancer and breast cancer risk reduction panels and chairs the survivorship panel. She has participated as a member of the Cancer Working Group for the Office of Research on Women=s Health for the National Institutes of Health, as a scientific reviewer for the breast and ovarian cancer research programs of the Department of Defense and the National Cancer Institute, as a reviewer for the NCI Special Emphasis Panel for Insight Awards to Stamp Out Breast Cancer and as a member of the NCI SPORE Program parent committee.

Title: Associate Professor of Oncology, Gynecology and Obstetrics
Institution: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Dr. Couzi is an Assistant Professor of Oncology at the Johns Hopkins University School of Medicine. She received her medical degree from the Royal College of Surgeons in Ireland in 1985. After internal medicine training in Ireland, she completed a fellowship in Medical Oncology at the Johns Hopkins Oncology Center. During that time, she also obtained a Masters degree in Clinical Epidemiology from the Johns Hopkins School of Hygiene and Public Health (1994). Her Master's thesis focused on quality of life issues among breast cancer survivors. In 1997, she joined the clinical faculty of the Department of Oncology at Johns Hopkins, serving as Assistant in Oncology from 1997-2000 and returning in 2004 as Assistant Professor of Oncology. She is board certified in Internal Medicine (1997) and Medical Oncology (1999), a member of the American Society of Clinical Oncology, and an admitted member of the Royal College of Physicians in Ireland. She currently maintains her clinical practice at Johns Hopkins at Greenspring Station.

Dr. Prowell received her B.A. with honors from Bard College in New York in 1994 and her M.D. from The Johns Hopkins University School of Medicine with election to Phi Beta Kappa Honor Society and Alpha Omega Alpha Honor Medical Society in 1999. She completed a residency in internal medicine at Johns Hopkins Hospital. She remained at Johns Hopkins for her fellowship in medical oncology at The Sidney Kimmel Comprehensive Cancer Center. During her fellowship, her areas of research interest were novel agents for breast cancer prevention, endocrine therapy for breast cancer, and prediction of response to breast cancer treatment. Dr. Prowell has received an American Society of Clinical Oncology Young Investigator Award and a Pearl M. Stetler Research Fund for Women Award for her breast cancer research. In 2006, Dr. Prowell accepted a joint appointment as a medical officer with the U.S. Food & Drug Administration's Division of Drug Oncology Products and as a part-time medical oncology faculty member in the Avon Foundation Breast Center at Johns Hopkins. Her goals are to provide outstanding clinical care to breast cancer patients and to promote public health by working to ensure that drugs for the prevention and treatment of breast cancer are safe and effective. Dr. Prowell is married with two children and lives in Howard County, Maryland.

Dr. Emens received her B.A. in Biochemistry and Cell Biology from the University of California at San Diego in 1984. She trained in the Medical Scientist Training Program at Baylor College of Medicine, receiving her Ph.D. in Cell Biology in 1993, and her M.D. in 1995. She completed her internship and residency in internal medicine at the University of Texas at Southwestern Medical School in 1998. Dr. Emens came to the Johns Hopkins Hospital in 1998, and completed fellowship training in medical oncology and hematology in 2001. She joined the faculty at the Johns Hopkins University School of Medicine in 2001 as an Associate Professor of Oncology. Dr. Emens is board-certified in internal medicine and medical oncology by the American Board of Internal Medicine, and her clinical interest in oncology is breast cancer. Dr. Emens has committed her career to the development of novel biologic therapies for breast cancer treatment and prevention, with an emphasis on vaccine- and monoclonal antibody-based immunotherapies. With formal training in both laboratory science and clinical medicine, her research is focused on testing immunotherapies and gene transfer technologies in clinical trials, and analyzing patient responses in the laboratory to identify new and pivotal immune and biologic targets for therapy. Dr. Emens is a member of the American Society of Clinical Oncology, the American Association for Cancer Research, and the American Society for Gene Therapy.

Dr. Fetting obtained his BA. from the College of the Holy Cross in Worchester, Massachusetts in 1971, and his MD. from the Johns Hopkins University School of Medicine in 1975. He was an Intern in Medicine at the Johns Hopkins Hospital in 1975-76; Assistant Resident in Medicine at Johns Hopkins in 1976-77; Resident in Psychiatry at Massachusetts General Hospital in boston from 1977-1980; Assistant in Oncology at the Johns Hopkins University School of Medicine from 1979-1981; Assistant in Medicine at Johns Hopkins University from 1979-1981, Member ; Associate Staff Johns Hopkins Hospital from 1979-1981; Research Associate in the Department of Pharmacology at Dartmouth Medical School in Hanover, New Hampshire in 1980; Instructor in Oncology at the Johns Hopkins University School of Medicine in 1981-82; Instructor in Medicine at the Johns Hopkins University School of Medicine in 1981-82; Instructor in Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine in 1981-82; Member Active Staff at Johns Hopkins Hospital since 1981 to present; Assistant Professor of Oncology at the Johns Hopkins School of Medicine from 1982-88; Assistant Professor of Medicine at the Johns Hopkins University School of Medicine from 1982-1990; Assistant Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine from 1982 to present; Associate Professor of Oncology at the Johns Hopkins University School of Medicine from 1998 to present; Associate Professor of Medicine at the Johns Hopkins University School of Medicine from 1990 to present. Dr. Fetting received his license to practice Medicine in the State of Maryland in 1975, Diplomate, Medial Oncology, American Board on Internal Medicine in 1983.

Carol received her BSN. from Towson State University in 1987. She then began working in the Oncology Center at Johns Hopkins on a solid tumor/bone marrow transplant unit. After eight years as a senior clinical nurse, Carol pursued her graduate program at Johns Hopkins University. She graduated in 1998 and obtained her Nurse Practitioner certification.

Carol began working in the breast center with the medical oncology group in October or 1998. Carol provides support, education, and medical care for patients receiving drug treatments; including chemotherapy, hormonal therapies, and biologic therapies.

Originally from Israel, Dr. Stearns completed a B.S. equivalent at Tel-Aviv University, Sackler Faculty of Medicine in 1989. After relocating to the United States, she completed her medical school training at the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, where she received her M.D. in 1992. Dr. Stearns completed her Internal Medicine residency at Georgetown University Medical Center in Washington, DC in 1995. She subsequently completed a two-year Fellowship in Medical Oncology at Georgetown University and the Lombardi Cancer Center. Dr. Stearns then conducted translational breast cancer research at Lombardi at first as a research fellow and then as an Instructor in Medicine and Oncology. Dr. Stearns was an Assistant Professor at the Lombardi Cancer Center at the Georgetown University in Washington, DC from 2000-2001 and an Assistant Professor of Internal Medicine from 2001-2002 at the University of Michigan Comprehensive Cancer Center in Ann Arbor, Michigan.

Dr. Stearns's long term research goal is to improve upon current practices by individualizing therapies for breast cancer. Her work also focuses on improving the quality of life of women who have survived the disease. She recently joined the faculty at the Breast Cancer Research Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Assistant Professor of Oncology and plans to continue and expand upon her work. She is a member of the American Society of Clinical Oncology and the American Association for Cancer Research.

Dr. Antonio Wolff received his medical degree from the Universidade Federal do Rio de Janeiro (Brazil, 1986). He completed an Internal Medicine residency at the Mount Sinai Medical Center (New York, 1991) and Medical Oncology fellowship at Johns Hopkins (Baltimore, 1995). He is an Associate Professor of Oncology and member of the Breast Cancer Program at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. His research interests are in the development of new treatment strategies and early predictive markers of benefit, such as imaging and circulating markers. He is a member of the Breast Cancer Committee of the Eastern Cooperative Oncology Group (ECOG), the Breast Cancer Guidelines Committee of the National Comprehensive Cancer Network (NCCN), and is chair-elect of the Health Services Committee of the American Society of Clinical Oncology. He is also interested in dissemination/implementation of practice guidelines, and needs assessments and educational needs of breast cancer patients. Dr. Wolff receives research funding from the National Cancer Institute, the Avon Foundation, and The Susan G. Komen Breast Cancer Foundation (local and national). Dr. Wolff maintains an active clinical practice dedicated exclusively to the care of patients with breast cancer.

Dr. Park is from Saginaw, MI and received his Bachelor's degree from The University of Chicago in 1989. He then completed a dual M.D.-Ph.D. training program at The University of Pennsylvania School of Medicine graduating in 1995. After completing a residency in Internal Medicine and Hematology/Oncology Fellowship Training at The Hospital of The University of Pennsylvania, he finished a postdoctoral research fellowship in cancer genetics in the laboratory of Dr. Bert Vogelstein at Johns Hopkins University. In 2002, Dr. Park joined the Faculty in the Department of Oncology at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins within the Breast Cancer Research Program. His laboratory research focuses on finding mutated or altered genes that are responsible for breast cancer initiation and progression, as well as genes that are mutated leading to chemo- and hormonal drug resistance.

Dr. Park's hobbies include telling bad jokes, visiting microbreweries and spending time with his wife and 2 year old daughter (not necessarily in that order).

Dr Visvanathan received her medical degree from the University of Sydney in Australia.She subsequently went on to complete her training in Internal Medicine and Medical Oncology at Royal Prince Alfred, a teaching hospital of the University of Sydney in Australia and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. In addition she undertook a Masters in Clinical/Cancer epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr Visvanathan currently has a joint faculty appointment in the John Hopkins School of Medicine and the Bloomberg School of Public Health. She is is one of 2 physicians who run the high-risk breast and ovarian clinic at Johns Hopkins in addition to seeing cancer patients. Trained as a medical oncologist and cancer epidemiologist, Dr Visvanathan's primary research interest is in the etiology, early detection and prevention of breast and ovarian cancer. In particular, the evaluation of genetic, molecular, and dietary biomarkers of risk and early detection with respect to breast cancer incidence and mortality, with an aim to modify those factors in the causal pathway with effective chemoprevention strategies.